Form 8-K - Current report:
SEC Accession No. 0001199835-24-000566
Filing Date
2024-12-27
Accepted
2024-12-27 11:26:33
Documents
15
Period of Report
2024-12-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 POINT OF CARE NANO-TECHNOLOGY, INC. 8-K pcnt_8k.htm   iXBRL 8-K 25537
2 MUTUAL RELEASE OF CLAIMS AGREEMENT pcnt_ex10-1.htm EX-10.1 18301
  Complete submission text file 0001199835-24-000566.txt   259597

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pcnt-20241220.xsd EX-101.SCH 3281
4 XBRL DEFINITION FILE pcnt-20241220_def.xml EX-101.DEF 26204
5 XBRL LABEL FILE pcnt-20241220_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE pcnt-20241220_pre.xml EX-101.PRE 24862
17 EXTRACTED XBRL INSTANCE DOCUMENT pcnt_8k_htm.xml XML 4592
Mailing Address 531 US HWY 22 EAST SUITE 232 WHITEHOUSE STATION NJ 08889
Business Address 531 US HWY 22 EAST SUITE 232 WHITEHOUSE STATION NJ 08889 732-723-7395
Point of Care Nano-Technology, Inc. (Filer) CIK: 0001504239 (see all company filings)

EIN.: 272830681 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-56356 | Film No.: 241583614
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)